Stevanato Group S.p.A.

STVN

IT0005452658

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 16:00:02 2024-05-31 EDT			5-day change	1st Jan Change
20.32 ^USD	+3.83%		+1.75%	-25.54%

05-30	Stevanato Group Inaugurates New Pharma Factory Near Rome	MT
05-30	Stevanato Group Unveils New Plant in Cisterna Di Latina for the Production of Pre-Sterilized Ez-Fill® Syringes and Cartridges	CI

Stevanato Group S.p.A. Provides Revenue Guidance for the Full Year 2022

May 10, 2022 at 06:30 am

Stevanato Group S.p.A. provided revenue guidance for the full year 2022. For the period, the company expects revenue in the range of €935 million to €945 million.

Latest news about Stevanato Group S.p.A.

Stevanato Group Inaugurates New Pharma Factory Near Rome	05-30	MT
Stevanato Group Unveils New Plant in Cisterna Di Latina for the Production of Pre-Sterilized Ez-Fill® Syringes and Cartridges	05-30	CI
Stevanato Appoints Franco Stevanato as Chief Executive Officer	05-28	MT
Stevanato Group S.P.A. Announces Chief Executive Officer Changes	05-28	CI
Stevanato Group S.p.A. Approves Dividend for the Year Ended December 31, 2023	05-24	CI
Stevanato Group S.p.A. Approves Board Appointments	05-24	CI
Certain Common Stock of Stevanato Group S.p.A. are subject to a Lock-Up Agreement Ending on 21-MAY-2024.	05-20	CI
Transcript : Stevanato Group S.p.A. Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM	05-15
Morgan Stanley Lowers Price Target on Stevanato Group to $26 From $30, Keeps Equalweight Rating	05-13	MT
UBS Adjusts Stevanato Price Target to $24 From $34, Maintains Neutral Rating	05-10	MT
Sector Update: Health Care Stocks Higher Late Afternoon	05-09	MT
Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading	05-09	MT
Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut; Shares Fall 22%	05-09	MT
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	05-09	MT
Sector Update: Health Care	05-09	MT
Transcript : Stevanato Group S.p.A., Q1 2024 Earnings Call, May 09, 2024	05-09
Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut	05-09	MT
Stevanato Group S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Stevanato Group S.P.A. Provides Revenue Guidance for 2024	05-09	CI
BNP Paribas Exane Initiates Stevanato Group With Outperform Rating	04-22	MT
Stevanato Group Names Ugo Gay as Chief Operations Officer	04-04	MT
Stevanato Group S.p.A. Announces the Appointment of Ugo Gay as Chief Operations Officer	04-04	CI
Stevanato Group Closes $379.7 Million Public Share Offering	03-27	MT
Stevanato Group Prices Upsized $330 Million Public Share Offering; Shares Rise	03-22	MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday	03-22	MT

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-04 - William Blair Growth Stock Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Stevanato Group S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

20.32 USD

Average target price

28.91 USD

Spread / Average Target

+42.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
STEVANATO GROUP S.P.A.	-25.54%	5.54B
ABBOTT LABORATORIES	-7.16%	178B
MEDTRONIC PLC	-1.23%	107B
BECTON, DICKINSON AND COMPANY	-4.86%	67.04B
DEXCOM, INC.	-4.28%	47.24B
CENCORA, INC.	+10.32%	44.62B
HOYA CORPORATION	+8.14%	42.5B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.76%	29.99B
TERUMO CORPORATION	+15.53%	25.22B
WEST PHARMACEUTICAL SERVICES, INC.	-5.88%	24.14B

Other Medical Equipment, Supplies & Distribution